DRC approves 4 experimental Ebola treatments in outbreak
Democratic Republic of the Congo's health ministry says four experimental treatments have been approved for use in the Ebola virus outbreak in its northeast.
The health ministry says ZMapp, Remdesivir, Favipiravir and Regn3450 - 3471 - 3479 now can be used. Health officials began using the mAb114 treatment on August 11 on 10 patients and the ministry says they are doing well.
The ministry says there are 75 confirmed Ebola cases and 27 probable ones. Of the 59 deaths, 32 have been confirmed as Ebola since the outbreak was announced on August 1 in North Kivu province.
More than 1 600 people have been vaccinated.
Insecurity in the region, especially in what the World Health Organisation calls "red zones" where several armed groups stage attacks, is hampering efforts to treat everyone.
* Sign up to News24's top Africa news in your inbox: SUBSCRIBE TO THE HELLO AFRICA NEWSLETTER